XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Net sales $ 1,668 $ 1,814 $ 5,116 $ 5,190
Cost of products sold 924 1,048 2,827 3,026
Gross profit 744 766 2,289 2,164
Selling and administrative expenses 267 301 828 899
Advertising costs 207 215 599 566
Research and development costs 27 32 89 93
Loss on divestiture 0 240 118 240
Pension settlement charge 0 0 0 171
Interest expense 23 22 66 69
Other (income) expense, net (34) (2) (79) 3
Earnings (losses) before income taxes 254 (42) 668 123
Income tax expense 63 8 180 52
Net earnings (losses) 191 (50) 488 71
Less: Net earnings attributable to noncontrolling interests 5 1 10 7
Net earnings (losses) attributable to Clorox $ 186 $ (51) $ 478 $ 64
Net earnings per share attributable to Clorox        
Basic net earnings (losses) per share (in dollars per share) $ 1.51 $ (0.41) $ 3.87 $ 0.52
Diluted net earnings (losses) per share (in dollars per share) $ 1.50 $ (0.41) $ 3.84 $ 0.52
Weighted average shares outstanding (in thousands)        
Basic (in shares) 123,367 124,249 123,643 124,133
Diluted (in shares) 124,066 124,249 124,468 124,721
Comprehensive income $ 196 $ 154 $ 467 $ 409
Less: Total comprehensive income attributable to noncontrolling interests 5 1 10 7
Total comprehensive income attributable to Clorox $ 191 $ 153 $ 457 $ 402